Daniel Pilsgaard Henriksen

M.D. PhD.

  • J. B. Winsløws Vej 19, 2.

    5000 Odense C

    Denmark

20112019
If you made any changes in Pure these will be visible here soon.

Personal profile

Research areas

Clinical Pharmacology

Pharmacoepidemiology

Respiratory Medicine

Research information

My primary research area is respiratory clinical pharmacology and pharmacoepidemiology, with a special interest in drug utilization and adverse effects. I am also involved in research regarding drug-induced kidney injury, and health services research.

External positions

Clinical assessor, Danish Medicines Agency, Copenhagen, Denmark.

1. Mar 2017 → …

External associate professor in clinical pharmacology, Klinisk Institut

1. Sep 2016 → …

Research areas

  • Pharmacology
  • Medicament
  • Respiratory medicine
  • Clinical biochemistry

Fingerprint Dive into the research topics where Daniel Pilsgaard Henriksen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 11 Similar Profiles
montelukast Medicine & Life Sciences
Hospital Emergency Service Medicine & Life Sciences
Cohort Studies Medicine & Life Sciences
Drug Utilization Medicine & Life Sciences
Population Medicine & Life Sciences
Lung Medicine & Life Sciences
Denmark Medicine & Life Sciences
Prescriptions Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2011 2019

Chronic Obstructive Pulmonary Disease
Adrenal Cortex Hormones
Drug Utilization
Cholinergic Antagonists
Drug Combinations
81 Downloads (Pure)

Etiology of Shock in the Emergency Department: A 12 Year Population Based Cohort Study

Holler, J. G., Jensen, H. K., Henriksen, D. P., Rasmussen, L. M., Mikkelsen, S., Pedersen, C. & Lassen, A. T., Jan 2019, In : Shock. 51, 1, p. 60-67

Research output: Contribution to journalJournal articleResearchpeer-review

Open Access
File
compound A 12
Hospital Emergency Service
Cohort Studies
Confidence Intervals
Population
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Clarithromycin
Pravastatin
Lovastatin
Area Under Curve

Progression-free survival in oncology: caveat emptor!

Bergmann, T. K., Christensen, M. M. H., Henriksen, D., Haastrup, M. B. & Damkier, P., 1. Mar 2019, In : Basic & Clinical Pharmacology & Toxicology. 124, 3, p. 240-244

Research output: Contribution to journalJournal articleResearchpeer-review

Oncology
Disease-Free Survival
Pharmaceutical Preparations
Health care
Neoplasms
Kidney Diseases
Creatinine
Pharmaceutical Preparations
Population
Prescriptions

Activities 2010 2014

Danish Emergency Medicine Conference 2014

Daniel Pilsgaard Henriksen (Participant)
20. Nov 201421. Nov 2014

Activity: Attending an eventConference organisation or participation

K12 - Sygdomme i huden: Dermatological drug interactions

Daniel Pilsgaard Henriksen (Participant)
22. May 201423. May 2014

Activity: Other activitiesOther

SU512 Basic Pharmacology - Interactions

Daniel Pilsgaard Henriksen (Participant)
2. Apr 2014

Activity: Other activitiesOther

Danish Emergency Medicine Conference

Daniel Pilsgaard Henriksen (Participant)
18. Apr 2013

Activity: Attending an eventConference organisation or participation

International Conference of Emergency Medicine

Daniel Pilsgaard Henriksen (Participant)
27. Jun 201230. Jun 2012

Activity: Attending an eventOrganisation or participation in workshops, courses or seminars

Press / Media

Biological therapy for severe asthma is not tested in correct patients

Uffe Bødtger, Daniel Pilsgaard Henriksen & Bo Lund Krogsgaard Chawes

29/03/2019

1 Media contribution

Press/Media: Press / Media

KORT NYT: Blodforgiftning er en overset dræber

Daniel Pilsgaard Henriksen

02/01/2015

1 item of Media coverage

Press/Media: Press / Media

En overset dræber

Daniel Pilsgaard Henriksen

02/10/2014

1 item of Media coverage

Press/Media: Press / Media